HPR12 Assessing COA Label Claims Based on Single-Arm Trials in Rare Diseases: A Review of US FDA Labels
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.1331
https://www.valueinhealthjournal.com/article/S1098-3015(23)04461-3/fulltext
Title :
HPR12 Assessing COA Label Claims Based on Single-Arm Trials in Rare Diseases: A Review of US FDA Labels
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04461-3&doi=10.1016/j.jval.2023.09.1331
First page :
Section Title :
Open access? :
No
Section Order :
10801